Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

4C-P

From Wikipedia, the free encyclopedia

Pharmaceutical compound
4C-P
Clinical data
Other names4C-Pr; 4C-PR; 4C-DOPR; 4C-DOPr; 4-Propyl-2,5-dimethoxy-α-ethylphenethylamine; 2,5-Dimethoxy-4-propyl-α-ethylphenethylamine
Drug classSerotonin5-HT2 receptoragonist;Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • 1-(2,5-dimethoxy-4-propylphenyl)butan-2-amine
PubChemCID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H25NO2
Molar mass251.370 g·mol−1
3D model (JSmol)
  • CCCC1=CC(=C(C=C1OC)CC(CC)N)OC
  • InChI=1S/C15H25NO2/c1-5-7-11-9-15(18-4)12(8-13(16)6-2)10-14(11)17-3/h9-10,13H,5-8,16H2,1-4H3
  • Key:JQUVOKBZTCXBPH-UHFFFAOYSA-N

4C-P, or4C-Pr, also known as4C-DOPR, as well as4-propyl-2,5-dimethoxy-α-ethylphenethylamine, is aserotonin5-HT2 receptoragonist of thephenethylamine,phenylisobutylamine, and4C families related toAriadne (4C-D).[1][2][3] It is a closeanalogue of thepsychedelic drugs2C-P andDOPR, with 2C-P having nosubstitution at theα carbon, DOPR having an α-methyl group, and 4C-P having an α-ethyl group.[2][4] The drug is apotentagonist of the serotonin5-HT2A,5-HT2B, and5-HT2C receptors.[2] It shows similarefficacy as an agonist of these receptors as Ariadne, but has about 6.2-fold higher potency as a serotonin 5-HT2A receptor agonist in comparison.[2] Like Ariadne, 4C-P produces an attenuatedhead-twitch response relative to DOPR, with a similar maximal response as Ariadne.[2] Thechemical synthesis of 4C-P has been described.[5][2] 4C-P waspatented in 1977[6] and first described in thescientific literature byAlexander Shulgin and colleagues in 1980.[5] Subsequently, it was described in greater detail by Michael Cunningham and colleagues in 2023.[2]

See also

[edit]

References

[edit]
  1. ^Duan W, Cao D, Wang S, Cheng J (January 2024). "Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants".Chemical Reviews.124 (1):124–163.doi:10.1021/acs.chemrev.3c00375.PMID 38033123.Ariadne (95) is a nonhallucinogenic 5-HT2AR agonist in the phenylalkylamine class of compounds,173 and its structure differs from that of DOM (91) by only an additional methyl group (Figure 11). A very recent SAR study by Cunningham et al. around ariadne showed that replacement of the 4-methyl group with a trifluoromethyl (96, 4C-TFM, EC50 = 28.6 nM, Emax = 79.9%) or an n-propyl (97, 4C-Pr, EC50 = 29.5 nM, Emax = 83.8%) led to good agonist potency at the 5-HT2AR in the Gq-dissociation BRET assay, while the cycolopropyl (98, 4CcycPr, EC50 = 153 nM, Emax = 75%) and MOM (99, 4C-MOM, EC50 = 441 nM, Emax = 77.8%) substitutions decreased compound potency.173 Ariadne showed lower signaling potency and efficacy compared to that of DOM in multiple signaling pathways examined, and it exhibited markedly more attenuated HTR effects than its hallucinogenic analogues.173
  2. ^abcdefgCunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, et al. (January 2023)."Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs".ACS Chemical Neuroscience.14 (1):119–135.doi:10.1021/acschemneuro.2c00597.PMC 10147382.PMID 36521179.
  3. ^Shulgin A, Manning T, Daley PF (2011).The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. p. 343.ISBN 978-0-9630096-3-0.OCLC 709667010.
  4. ^Trachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag.ISBN 978-3-03788-700-4.OCLC 858805226. Archived fromthe original on 21 August 2025.
  5. ^abStandridge RT, Howell HG, Tilson HA, Chamberlain JH, Holava HM, Gylys JA, et al. (February 1980). "Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes".Journal of Medicinal Chemistry.23 (2):154–162.doi:10.1021/jm00176a010.PMID 7359529.
  6. ^US 4034113A, Shulgin AT, "Treatment of senile geriatric patients to restore performance", issued 5 July 1977 

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=4C-P&oldid=1333054218"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp